Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised phase II trial of intratumoural hydrogen peroxide as a radiation sensitiser in locally advanced/recurrent breast cancer
2019-001709-25Phase 2Unknown
- Sponsor
- The Institute of Cancer Research
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of hydrogen peroxide in breast cancer (2 arms), sponsored by The Institute of Cancer Research. Primary endpoint: Complete tumour response at 12 months post-radiotherapy. Status: unknown.
02
Drugs
hydrogen peroxide
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2019-001709-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001709-25.